Aspira Women's Health Inc. (AWHL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 3.5M 7M 10.5M FY10: 1.2M FY11: 1.9M FY12: 2.1M FY13: 2.6M FY14: 2.5M FY15: 2.2M FY16: 2.6M FY17: 3.1M FY18: 3.1M FY19: 4.5M FY20: 4.7M FY21: 6.8M FY22: 8.2M FY23: 9.2M FY24: 9.2M FY25: 9.2M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

-2.5M 0 2.5M 5M 7.5M FY10: 1.1M FY11: 1.8M FY12: 2M FY13: 2.4M FY14: 1.3M FY15: -132K FY16: -56K FY17: 207K FY18: -89K FY19: 1.2M FY20: 1.2M FY21: 3.1M FY22: 4.3M FY23: 5.3M FY24: 5.5M FY25: 5.9M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M FY10: -14.6M FY11: -17.6M FY12: -9.4M FY13: -8.9M FY14: -19.2M FY15: -19.2M FY16: -15M FY17: -10.4M FY18: -11.3M FY19: -15.3M FY20: -18M FY21: -32.6M FY22: -31.1M FY23: -18.9M FY24: -16.3M FY25: -7.9M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-45M -30M -15M 0 15M 30M 45M FY10: -19M FY11: -17.8M FY12: -7.1M FY13: -8.8M FY14: -19.2M FY15: -19.1M FY16: -15M FY17: -10.5M FY18: -11.4M FY19: -15.2M FY20: -17.9M FY21: -31.7M FY22: -29.9M FY23: -16.7M FY24: -13.1M FY25: -12.8M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 1.5M 3M 4.5M FY10: 88K FY11: 129K FY12: 131K FY13: 170K FY15: 2.3M FY16: 2.7M FY17: 2.9M FY18: 3.1M FY19: 3.3M FY20: 3.4M FY21: 3.8M FY22: 3.9M FY23: 3.9M FY24: 3.7M FY25: 3.3M FY10 FY12 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY10: -20.9M FY11: -15.6M FY12: -10.4M FY13: -8.2M FY14: -16.8M FY15: -18.4M FY16: -14M FY17: -8.1M FY18: -9.4M FY19: -13M FY20: -14.7M FY21: -27.4M FY22: -31.1M FY23: -15.9M FY24: -12.1M FY25: -7M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY10: -21.1M FY11: -15.7M FY12: -10.4M FY13: -8.5M FY14: -17.1M FY15: -18.6M FY16: -15.2M FY17: -8.2M FY18: -9.5M FY19: -13.1M FY20: -15.2M FY21: -27.6M FY22: -31.3M FY23: -15.9M FY24: -12.2M FY25: -7M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 35M 70M 105M FY11: 14.2M FY12: 15M FY13: 20.9M FY14: 36.1M FY15: 47.1M FY16: 52.2M FY17: 56.9M FY18: 70.1M FY19: 86.6M FY20: 100.7M FY21: 7.4M FY22: 7.8M FY23: 9.2M FY24: 14.1M FY25: 34.1M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-9.00 -6.00 -3.00 0.00 3.00 6.00 9.00 Q1 '11: -1.05 Q2 '11: -1.37 Q3 '11: -1.42 Q4 '11: -1.25 Q1 '12: -1.03 Q2 '12: -0.77 Q3 '12: -0.59 Q4 '12: -0.47 Q1 '13: -0.52 Q2 '13: -0.50 Q3 '13: -0.47 Q4 '13: -0.44 Q1 '14: -0.38 Q2 '14: -0.42 Q3 '14: -0.48 Q4 '14: -0.53 Q1 '15: -0.52 Q2 '15: -0.48 Q3 '15: -0.42 Q4 '15: -0.41 Q1 '16: -0.40 Q2 '16: -0.36 Q3 '16: -0.33 Q4 '16: -0.29 Q1 '17: -0.25 Q2 '17: -0.22 Q3 '17: -0.21 Q4 '17: -0.20 Q1 '18: -0.20 Q2 '18: -0.20 Q3 '18: -0.18 Q4 '18: -0.16 Q1 '19: -0.16 Q2 '19: -0.18 Q3 '19: -0.18 Q4 '19: -0.19 Q1 '20: -0.18 Q2 '20: -0.16 Q3 '20: -0.16 Q4 '20: -0.18 Q1 '21: -0.19 Q2 '21: -0.21 Q3 '21: -0.26 Q4 '21: -4.27 Q1 '22: -5.46 Q2 '22: -6.50 Q3 '22: -7.41 Q4 '22: -3.86 Q1 '23: -3.41 Q2 '23: -2.59 Q3 '23: -2.07 Q4 '23: -1.82 Q1 '24: -1.42 Q2 '24: -1.42 Q3 '24: -1.17 Q4 '24: -0.95 Q1 '25: -0.65 Q2 '25: -0.44 Q3 '25: -0.34 Q4 '25: -0.36 Q4 '11 Q4 '13 Q4 '15 Q4 '17 Q4 '19 Q4 '21 Q4 '23 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.